Vivani Medical began the LIBERATE-1 trial, testing a six-month exenatide implant for chronic weight management in Australia. The study uses NanoPortal technology, with results expected in mid-2025 and ...
We are currently living in the age of Ozempic. Millions of people are utilizing these GLP-1 drugs to shed pounds, so much so that adult obesity dropped for the first time in a decade. However, the ...
VIENNA — Exercise to maintain weight loss reduced atherosclerosis progression and improved cardiovascular biomarkers, while GLP-1 therapy alone didn’t, according to a randomized trial in people with ...